Suppr超能文献

文拉法辛、帕罗西汀和阿米替林在抑郁症治疗中的耐受性比较。

Comparison of tolerance of venlafaxine, paroxetine and amitriptyline in depression therapy.

作者信息

Miskovic Mirjana

机构信息

Psychiatric Clinic, University Clinical Center of Banja Luka, Banja Luka, Bosnia and Herzegovina.

出版信息

Med Arch. 2015 Apr;69(2):107-9. doi: 10.5455/medarh.2015.69.107-109. Epub 2015 Apr 6.

Abstract

INTRODUCTION

There are no controlled studies dedicated to research of side effects of antidepressants. It is a well known fact that antidepressants reciprocally differ according to their type, intensity and frequency of appearance of certain side effects. For example, cardiovascular and anticholinergic effects are essential feature of the tricyclics whereas gastrointestinal and sexual side effects are registered during the use of selective serotonin reuptake inhibitors. Interruptions of therapy or irregular use of drugs because of the appearance of side effects are not rare. Serious side effects of drugs are the fourth cause of death in the USA.

AIM

The aim of this study is the evaluation of appearance of side effects comparing three different groups of antidepressants: venlafaxine, amitriptyline and paroxetine.

MATERIAL AND METHODS

The study included 90 in-patients as well as outpatients of both sexes aged 18-65 who were treated for major depressive disorder at Psychiatric Clinic in Banjaluka. 30 patients were treated with amitriptyline 75-250 mg, 30 patients were treated with paroxetine 20-40 mg and 30 patients were treated with venlafaxine 75-300 mg. The selection of patients was done on the basis of diagnosis of major depressive disorder.

RESULTS

Most patients did not have serious side effects. The study confirmed high efficiency of the mentioned drugs as well as the fact that paroxetine causes a bit more side effects in comparison with two other antidepressants.

摘要

引言

目前尚无专门针对抗抑郁药副作用研究的对照研究。众所周知,抗抑郁药因其某些副作用的类型、强度和出现频率而相互不同。例如,心血管和抗胆碱能作用是三环类药物的主要特征,而在使用选择性5-羟色胺再摄取抑制剂期间会出现胃肠道和性方面的副作用。由于副作用而中断治疗或不规律用药的情况并不罕见。在美国,药物的严重副作用是第四大死因。

目的

本研究的目的是比较三种不同组别的抗抑郁药(文拉法辛、阿米替林和帕罗西汀)副作用的出现情况。

材料与方法

该研究纳入了90名年龄在18至65岁之间的住院患者和门诊患者,他们在巴尼亚卢卡的精神病诊所接受重度抑郁症治疗。30名患者接受75 - 250毫克阿米替林治疗,30名患者接受20 - 40毫克帕罗西汀治疗,30名患者接受75 - 300毫克文拉法辛治疗。患者的选择基于重度抑郁症的诊断。

结果

大多数患者没有严重副作用。该研究证实了上述药物的高效性,以及与其他两种抗抑郁药相比,帕罗西汀引起的副作用略多这一事实。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e5/4429990/b4348db03607/MA-69-107-g004.jpg

相似文献

1
Comparison of tolerance of venlafaxine, paroxetine and amitriptyline in depression therapy.
Med Arch. 2015 Apr;69(2):107-9. doi: 10.5455/medarh.2015.69.107-109. Epub 2015 Apr 6.
2
Platelet counts in depressed patients treated with amitriptyline or paroxetine.
Eur Psychiatry. 2003 Mar;18(2):89-91. doi: 10.1016/s0924-9338(03)00006-3.
3
The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
Eur Arch Psychiatry Clin Neurosci. 2009 Apr;259(3):172-85. doi: 10.1007/s00406-008-0849-0. Epub 2009 Jan 22.
5
Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline.
Breast Cancer Res Treat. 2001 Nov;70(1):1-10. doi: 10.1023/a:1012518831494.
10
Paroxetine and amitriptyline in the treatment of depression in general practice.
Acta Psychiatr Scand. 1996 Mar;93(3):158-63. doi: 10.1111/j.1600-0447.1996.tb10623.x.

引用本文的文献

1
Psychotropic Drugs for the Management of Chronic Pain and Itch.
Pharmaceuticals (Basel). 2019 Jun 24;12(2):99. doi: 10.3390/ph12020099.

本文引用的文献

3
Changes in weight during a 1-year trial of fluoxetine.
Am J Psychiatry. 1999 Aug;156(8):1170-6. doi: 10.1176/ajp.156.8.1170.
6
Antidepressants.
J Clin Psychiatry. 1997;58 Suppl 6:9-25.
7
Medications used to prevent migraine headaches and their potential ocular adverse effects.
Optom Vis Sci. 1995 Dec;72(12):879-91. doi: 10.1097/00006324-199512000-00006.
9
Occurrence of myoclonus in patients treated with cyclic antidepressants.
Arch Gen Psychiatry. 1987 Mar;44(3):269-72. doi: 10.1001/archpsyc.1987.01800150081010.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验